Background: Despite the promising effectiveness of clinical trials on breast cancer prevention, treatment, and survival within communities of color, disparities in morbidity and/or mortality remain persistent. Improving minority participation in breast cancer clinical trials using culturally aligned strategies has the potential to improve cancer disparities for these communities. ^ Objectives and methods: This dissertation aims to identify key strategies that promote diversity in breast cancer clinical trial participation using two studies: (1) a systematic review of the evidence was undertaken with the goal of better understanding the state of the current literature on the recruitment of minorities to breast cancer clinical trials. This...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Despite the promising effectiveness of clinical trials on breast cancer prevention, trea...
Background: Study populations in clinical research must reflect US changing demographics, especially...
Improvements in screening and treatment methods have resulted in a growing number of breast cancer s...
Background: Study populations in clinical research must reflect US changing demographics, especially...
Improvements in screening and treatment methods have resulted in a growing number of breast cancer s...
Clinical trials are the established research mechanism designed to examine how new medical therapies...
PURPOSE:: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproporti...
Younger breast cancer survivors often lead extremely busy lives with multiple demands and responsibi...
Younger breast cancer survivors often lead extremely busy lives with multiple demands and responsibi...
Younger breast cancer survivors often lead extremely busy lives with multiple demands and responsibi...
PURPOSE:: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproporti...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Despite the promising effectiveness of clinical trials on breast cancer prevention, trea...
Background: Study populations in clinical research must reflect US changing demographics, especially...
Improvements in screening and treatment methods have resulted in a growing number of breast cancer s...
Background: Study populations in clinical research must reflect US changing demographics, especially...
Improvements in screening and treatment methods have resulted in a growing number of breast cancer s...
Clinical trials are the established research mechanism designed to examine how new medical therapies...
PURPOSE:: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproporti...
Younger breast cancer survivors often lead extremely busy lives with multiple demands and responsibi...
Younger breast cancer survivors often lead extremely busy lives with multiple demands and responsibi...
Younger breast cancer survivors often lead extremely busy lives with multiple demands and responsibi...
PURPOSE:: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproporti...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. ...